46 results on '"Tavor, Sigal"'
Search Results
2. The ability to cross the blood–cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts
3. Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practice
4. Utilization of Antifungal Prophylaxis and Treatment for Newly Diagnosed AML Patients Treated with Venetoclax Based Regimens in Routine Clinical Practice - a Prospective Analysis from the Revive Study
5. Clinical Predictors for Relapse Among Patients with AML Who Responded to Venetoclax-Based Treatment - a Real-World Prospective Analysis from the Revive Study Group
6. Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia
7. High Response Rate for Treatment With Gemtuzumab Ozogamicin and Cytarabine in Elderly Patients With Acute Myeloid Leukemia and Favorable and Intermediate-I Cytogenetic Risk
8. Real World Prospective Observational Multicenter Trial of Venetoclax-Based Therapy for Patients with AML Reveals Unique Patterns of Patient Selection and Treatment Utilization - Revive Study
9. The Pattern of Use of PET/CT Scans in the Clinical Management of Chronic Lymphocytic Leukemia
10. Engraftment of human blood malignancies to the turkey embryo: A robust new in vivo model
11. First Results from a Nationwide Prospective Non-Interventional Study of Venetoclax-Based 1st Line Therapies in Patients with Acute Myeloid Leukemia (AML) - Revive Study
12. Dasatinib Inhibits FLT3/ITD and PTPN11mutated Acute Myeloid Leukemia Cells Overexpressing SRC Tyrosine Kinases
13. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6
14. Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells
15. Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells
16. Macrophage functional maturation and cytokine production are impaired in C/EBPε-deficient mice
17. C/EBP-β, C/EBP-δ, PU.1, AML1 genes: mutational analysis in 381 samples of hematopoietic and solid malignancies
18. Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias
19. Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia
20. Abstract 4430: Loss of the histone methyltransferase EZH2 induces chemoresistance in acute myeloid leukemia (AML)
21. BL-8040, a CXCR4 antagonist, synergizes with the FLT3 inhibitor AC220 inducing apoptosis and reducing minimal residual disease to prolong survival of AML diseased mice
22. Ruxolitinib Treatment for Myelofibrosis: Efficacy and Tolerability in a Real-World Setting
23. The CXCR4 Antagonist BL-8040 Efficiently Induces Apoptosis and Inhibits The Survival Of AML Cells
24. Loss Of H3K27 Trimethylation (H3K27me3) Associates With a Multi Drug Resistance Phenotype In Acute Myeloid Leukemia (AML)
25. Role of CXCR4 in the Pathogenesis of Acute Myeloid Leukemia
26. Tyrosine Kinase Inhibitors Induced Immune Thrombocytopenia in Chronic Myeloid Leukemia?
27. Predictive value of TP53 fluorescencein situhybridization in cytogenetic subgroups of acute myeloid leukemia
28. Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?
29. The Predictive Value of TP53 FISH Analysis for Treatment Response and Survival in Cytogenetic Subgroups of AML Patients.
30. The stromal derived factor-1\CXCR4 axis – a legitimate therapeutic target in multiple myeloma?
31. The CXCR4 Antagonist AMD3100 Impairs Survival of AML Cells and Induces Their Differentiation.
32. Functional CXCR4 Expressing Microparticles and SDF-1 Correlate with Circulating AML Cell Counts.
33. Inhibition of Elastase or SDF-1/CXCR4 Axis Promotes Differentiation of Human AML Cells.
34. Functional CXCR4-Expressing Microparticles and SDF-1 Correlate with Circulating Acute Myelogenous Leukemia Cells
35. Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice
36. Motility, Proliferation and Egress of Human AML Cells in Transplanted NOD/SCID Mice Are Regulated by Membrane Bound and Secreted Elastase.
37. CXCR4 Regulates Migration and Development of Human Acute Myelogenous Leukemia Stem Cells in Transplanted NOD/SCID Mice
38. Restoration of C/EBPα Expression in a BCR-ABL+ Cell Line Induces Terminal Granulocytic Differentiation
39. Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors
40. Analysis of the CHK2 Gene in Lymphoid Malignancies
41. Predictive value of TP53 fluorescence in situ hybridization in cytogenetic subgroups of acute myeloid leukemia.
42. Restoration of C/EBPα Expression in BCR-ABL[sup +] Cell Line Induces Terminal Granulocytic Differentiation.
43. Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors.
44. First Results from a Nationwide Prospective Non-Interventional Study of Venetoclax-Based 1stLine Therapies in Patients with Acute Myeloid Leukemia (AML) - Revive Study
45. Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature.
46. Correlation between CXCR4 and homing or engraftment of acute myelogenous leukemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.